Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study
- PMID: 11535564
- DOI: 10.1161/hc3501.095214
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study
Abstract
Background: Despite consensus on the need for blood cholesterol reductions to prevent coronary heart disease (CHD), available evidence on optimal cholesterol levels or the added predictive value of additional lipids is sparse.
Methods and results: After 10 years follow-up of 12 339 middle-aged participants free of CHD in the Atherosclerosis Risk in Communities Study (ARIC), 725 CHD events occurred. The lowest incidence was observed in those at the lowest LDL cholesterol (LDL-C) quintile, with medians of 88 mg/dL in women and 95 mg/dL in men, and risk accelerated at higher levels, with relative risks (RRs) for the highest quintile of 2.7 in women and 2.5 in men. LDL-C, HDL-C, lipoprotein(a) [Lp(a)], and in women but not men, triglycerides (TG) were all independent CHD predictors, providing an RR, together with blood pressure, smoking, and diabetes, of 13.5 in women and 4.9 in men. Lp(a) was less significant in blacks than whites. Prediction was not enhanced by HDL-C density subfractions or apolipoproteins (apo) A-I or B. Despite strong univariate associations, apoB did not contribute to risk prediction in subgroups with elevated TG, with lower LDL-C, or with high apoB relative to LDL-C.
Conclusions: Optimal LDL-C values are <100 mg/dL in both women and men. LDL-C, HDL-C, TG, and Lp(a), without additional apolipoproteins or lipid subfractions, provide substantial CHD prediction, with much higher RR in women than men.
Comment in
-
Serum triglyceride concentration and coronary heart disease.Circulation. 2002 Feb 26;105(8):e54. Circulation. 2002. PMID: 11864938 No abstract available.
Similar articles
-
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.Circulation. 2005 Nov 29;112(22):3375-83. doi: 10.1161/CIRCULATIONAHA.104.532499. Circulation. 2005. PMID: 16316964
-
Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.Arterioscler Thromb. 1994 Jul;14(7):1098-104. doi: 10.1161/01.atv.14.7.1098. Arterioscler Thromb. 1994. PMID: 8018665
-
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.JAMA. 2007 Aug 15;298(7):776-85. doi: 10.1001/jama.298.7.776. JAMA. 2007. PMID: 17699011
-
Cholesterol, lipoproteins, and coronary heart disease in women.Clin Chem. 1988;34(8B):B60-70. Clin Chem. 1988. PMID: 3042201 Review.
-
Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease.Med Clin North Am. 1994 Jan;78(1):99-115. doi: 10.1016/s0025-7125(16)30178-x. Med Clin North Am. 1994. PMID: 8283937 Review.
Cited by
-
Total Outflow of High-Density Lipoprotein-Cholesteryl Esters from Plasma Is Decreased in a Model of 3/4 Renal Mass Reduction.Int J Mol Sci. 2023 Dec 4;24(23):17090. doi: 10.3390/ijms242317090. Int J Mol Sci. 2023. PMID: 38069414 Free PMC article.
-
Ethanol-mediated upregulation of APOA1 gene expression in HepG2 cells is independent of de novo lipid biosynthesis.Lipids Health Dis. 2020 Jun 20;19(1):144. doi: 10.1186/s12944-020-01309-4. Lipids Health Dis. 2020. PMID: 32563265 Free PMC article.
-
Association of blood lipids, creatinine, albumin, and CRP with socioeconomic status in Malawi.Popul Health Metr. 2013 Feb 28;11(1):4. doi: 10.1186/1478-7954-11-4. Popul Health Metr. 2013. PMID: 23448548 Free PMC article.
-
Atherogenic dyslipidemia: cardiovascular risk and dietary intervention.Lipids. 2010 Oct;45(10):907-14. doi: 10.1007/s11745-010-3408-1. Epub 2010 Jun 4. Lipids. 2010. PMID: 20524075 Free PMC article. Review.
-
A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk.Clinicoecon Outcomes Res. 2018 Oct 8;10:601-609. doi: 10.2147/CEOR.S172838. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 30349338 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous